Anxiety and Related Sleep Disorders - Baltics

Revenue in the Anxiety and Related Sleep Disorders market is projected to reach US$24.70m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 1.26%, resulting in a market volume of US$26.29m by 2029.
In global comparison, most revenue will be generated United States (US$3.21bn in 2024).
In relation to total population figures, per person revenues of US$81.44 are generated in 2024.

The Anxiety and Related Sleep Disorders market covers sales of three drug classes: anxiolytics, hypnotics, and sedatives. These classes contain different types of drugs, such as benzodiazepines, anticonvulsants, and antihistamines, that reduce anxiety and insomnia symptoms caused by anxiety. These medications mainly fall into the category of prescription drugs.

Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.

Company examples: Pfizer, Bristol-Myers Squibb, GlaxoSmithKline PLC, Johnson & Johnson, and Merck & Co.

Pharmaceutical sales and consumption of anxiolytics
Pharmaceutical sales and consumption hypnotics and sedatives

Non-mental health related sleep disorders
Any other anxiety medications
Psychotherapy

The Anxiety and Related Sleep Disorders market in Baltics has been experiencing significant growth in recent years.

Customer preferences: Customers in the Baltics are increasingly seeking solutions for anxiety and sleep disorders. This can be attributed to several factors, including the rising awareness and understanding of mental health issues, as well as the increasing stress levels in modern society. As a result, there is a growing demand for products and services that can help individuals manage their anxiety and improve their sleep quality.

Trends in the market: One of the key trends in the Anxiety and Related Sleep Disorders market in Baltics is the growing popularity of natural and holistic remedies. Customers are increasingly looking for products that are derived from natural ingredients and have minimal side effects. This trend is driven by a desire for more sustainable and healthier alternatives to traditional pharmaceutical options. As a result, there has been a surge in the availability of natural supplements, herbal remedies, and alternative therapies in the market.Another trend in the market is the increasing use of technology to address anxiety and sleep disorders. With the rise of digital health solutions, customers now have access to a wide range of mobile applications, wearable devices, and online platforms that offer personalized support and guidance. These technological advancements have made it easier for individuals to track their sleep patterns, practice mindfulness techniques, and receive virtual therapy sessions, all from the comfort of their own homes.

Local special circumstances: The Baltics, comprising Estonia, Latvia, and Lithuania, have their own unique set of circumstances that contribute to the development of the Anxiety and Related Sleep Disorders market. These countries have experienced significant economic growth and societal changes in recent years, leading to increased levels of stress and anxiety among the population. Additionally, the high prevalence of seasonal affective disorder (SAD) in the region, due to long winters with limited daylight, has also contributed to the demand for anxiety and sleep disorder solutions.

Underlying macroeconomic factors: The growth of the Anxiety and Related Sleep Disorders market in the Baltics can be attributed to several underlying macroeconomic factors. Firstly, the region has witnessed a steady increase in disposable income, allowing individuals to allocate more resources towards their mental health and well-being. Secondly, the growing healthcare infrastructure and access to healthcare services have made it easier for individuals to seek professional help for their anxiety and sleep disorders. Lastly, the favorable regulatory environment and government initiatives promoting mental health awareness have also played a role in driving the market growth.In conclusion, the Anxiety and Related Sleep Disorders market in Baltics is experiencing significant growth due to customer preferences for natural and holistic remedies, the increasing use of technology, and the unique local circumstances. These trends are supported by underlying macroeconomic factors such as rising disposable income, improved healthcare infrastructure, and government initiatives. As the market continues to evolve, it is expected to witness further expansion and innovation in the coming years.

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Despite what some may think, mental health problems are common in the United States and around the world. Mental health issues, much like other health issues, can be mild, but can also be life altering, affecting the emotional, social, and psychological well-being of the person. Common types of mental illness include mood disorders, anxiety disorders, eating disorders, and personality disorders. Although symptoms of mental illness differ depending on the type of illness and seriousness of the problem, common symptoms of mental health issues include changes in sleeping and eating habits, social withdrawal, feelings of hopelessness, anger, and prolonged sadness, suicidal thoughts, and substance abuse. In 2022, it was estimated that around 36 percent of those in the U.S. aged 18 to 25 years and 29 percent of those aged 26 to 49 years suffered from some form of mental illness in the past year.